Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7950 results

Sort By:

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Study ID: NCT06926894
Start Date: 2025-04
End Date: 2030-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Rapidly generated virus specific T (R-MVST) cells

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

Study ID: NCT06414460
Start Date: 2025-04-25
End Date: 2029-03-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

80

Intervention / Treatment

ISM3412

Sponsor

InSilico Medicine Hong Kong Limited

Source: clinicaltrials.gov

Share:
Add to list

Met Non Small Cell Cancer Registry (MOMENT)

Study ID: NCT05376891
Start Date: 2022-10-04
End Date: 2027-03-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

700

Intervention / Treatment
Sponsor

EMD Serono Research & Development Institute, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

Study ID: NCT03164460
Start Date: 2017-05-22
End Date: 2025-05-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Intensity-Modulated Radiation Therapy

Proton Radiation

Stereotactic Body Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy

Study ID: NCT05115760
Start Date: 2022-04-05
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Dietary Supplement

Quality-of-Life Assessment

Administration questionnaire

Sponsor

Jonsson Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Study ID: NCT06273176
Start Date: 2023-01-01
End Date: 2028-01-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

225

Intervention / Treatment

Awake mapping under local anesthesia

Asleep mapping under general anesthesia

Resection under general anesthesia without mapping

Sponsor

Erasmus Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery

Study ID: NCT05954676
Start Date: 2023-07-17
End Date: 2025-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Careorbit

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Study ID: NCT04301076
Start Date: 2021-08-31
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Biospecimen Collection

Bone Marrow Biopsy

Computed Tomography

Cyclophosphamide

Doxorubicin Hydrochloride

Etoposide

Lenalidomide

Positron Emission Tomography

Prednisone

Vincristine Sulfate

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning

Study ID: NCT05864976
Start Date: 2023-12-06
End Date: 2030-01-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Support Vector Machine

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

Study ID: NCT01638676
Start Date: 2012-07
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

55

Intervention / Treatment

Rampheinibi

Metformin

Sponsor

University of Louisville

Source: clinicaltrials.gov

Share:
Add to list